BIOGEN for BIOGEN
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug cost and pricing policy Patient affordability issues policy proposals related to clinical trial diversity Issues related to the 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON NICHOLAS BADIDA New | — |
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA New | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) International tax issues, including Pillar 1 and Pillar 2
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Trade (domestic/foreign) TRD
Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care H.R.19, Lower Costs, More Cures Act of 2021 H.R. 5376, Inflation Reduction Act, including provisions related to corporate taxes, Medicare, and prescription drug pricing H.R.7667, Food and Drug Amendments of 2022 User Fee Agreements, specifically reauthorization of PDUFA and BSUFA Aduhelm National Coverage Determination
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| JOHN RAYMOND GIBSON | — |
| TYLER HANSON | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
| ALI LAKHANI | — |
Medicare/Medicaid MMM
Drug cost and pricing policy issues Issues regarding coverage, coding, and reimbursement issues Issues regarding Alzheimer's treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
| KATHLEEN KONKA New | — |
Budget/Appropriations BUD
H.R.4373, Further Additional Continuing Appropriations and Extensions Act, 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.